Effect of masupirdine (SUVN‐502) on cognition in patients with moderate Alzheimer's disease: A randomized, double‐blind, phase 2, proof‐of‐concept study

por Nirogi, Ramakrishna, Ieni, John, Goyal, Vinod Kumar, Ravula, Jyothsna, Jetta, Satish, Shinde, Anil, Jayarajan, Pradeep, Benade, Vijay, Palacharla, Veera Raghava Chowdary, Dogiparti, Dhanunjay Kumar, Jasti, Venkat, Atri, Alireza, Cummings, Jeffrey
Publicado 2022